Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,260 | 168 | 95.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $94.62 | 4 | 2.8% |
| Education | $75.00 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $437.26 | 21 | $0 (2020) |
| UCB, Inc. | $430.91 | 23 | $0 (2024) |
| Lilly USA, LLC | $363.32 | 17 | $0 (2024) |
| GENZYME CORPORATION | $350.45 | 17 | $0 (2019) |
| Amgen Inc. | $344.25 | 10 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $172.35 | 12 | $0 (2020) |
| EMD Serono, Inc. | $162.32 | 12 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $140.09 | 8 | $0 (2020) |
| Biogen, Inc. | $131.09 | 7 | $0 (2019) |
| Eisai Inc. | $114.65 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $253.09 | 10 | ABBVIE INC. ($51.10) |
| 2020 | $320.30 | 15 | Lilly USA, LLC ($143.07) |
| 2019 | $1,575 | 87 | Teva Pharmaceuticals USA, Inc. ($247.46) |
| 2018 | $1,044 | 47 | UCB, Inc. ($241.67) |
| 2017 | $237.64 | 14 | Teva Pharmaceuticals USA, Inc. ($51.48) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Neuroscience | ||||||
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: PAIN | ||||||
| 07/31/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Neurology | ||||||
| 05/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: Neurology | ||||||
| 05/21/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: IMMUNOLOGY | ||||||
| 05/20/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Neurology | ||||||
| 04/23/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Neurology | ||||||
| 02/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $51.10 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: NEUROLOGY | ||||||
| 03/11/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: CNS | ||||||
| 03/10/2020 | Lilly USA, LLC | REYVOW (Drug) | Food and Beverage | In-kind items and services | $96.76 | General |
| Category: Neuroscience | ||||||
| 03/10/2020 | Lilly USA, LLC | REYVOW (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Neuroscience | ||||||
| 03/10/2020 | Lilly USA, LLC | REYVOW (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: Neuroscience | ||||||
| 03/03/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $10.09 | General |
| Category: Neuroscience | ||||||
| 02/26/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Central Nervous System | ||||||
| 02/20/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Neurology | ||||||
| 02/19/2020 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: NEUROSCIENCE | ||||||
| 02/05/2020 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Neuroscience | ||||||
| 02/04/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Neuroscience | ||||||
| 01/28/2020 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2020 | Adamas Pharmaceuticals, Inc. | GOCOVRI (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: PD | ||||||
| 01/15/2020 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Neurology | ||||||
| 01/09/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Central Nervous System | ||||||
| 01/07/2020 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $20.14 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 256 | 356 | $52,805 | $28,618 |
| 2022 | 6 | 326 | 504 | $71,540 | $39,859 |
| 2021 | 5 | 153 | 235 | $35,085 | $21,728 |
| 2020 | 6 | 253 | 378 | $69,250 | $38,216 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 78 | 132 | $16,500 | $7,943 | 48.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 79 | $11,850 | $7,908 | 66.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 58 | 59 | $11,210 | $5,717 | 51.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $6,300 | $3,829 | 60.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 25 | 25 | $3,500 | $1,605 | 45.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 19 | 19 | $2,185 | $810.73 | 37.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 21 | $1,260 | $806.19 | 64.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 150 | $22,500 | $15,096 | 67.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 92 | 162 | $20,250 | $8,980 | 44.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 75 | 75 | $14,250 | $7,639 | 53.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 45 | 46 | $6,440 | $3,552 | 55.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $4,800 | $2,963 | 61.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 43 | 55 | $3,300 | $1,628 | 49.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 55 | 123 | $18,450 | $12,755 | 69.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 21 | 21 | $6,300 | $3,770 | 59.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 21 | 21 | $3,990 | $2,204 | 55.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 26 | 33 | $4,125 | $1,875 | 45.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 30 | 37 | $2,220 | $1,124 | 50.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 98 | 185 | $27,750 | $14,122 | 50.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 50 | 52 | $13,000 | $7,953 | 61.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 44 | 70 | $8,750 | $5,983 | 68.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 35 | 36 | $9,900 | $5,030 | 50.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 15 | 23 | $8,050 | $4,100 | 50.9% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 11 | 12 | $1,800 | $1,027 | 57.1% |
About Dr. Elmoataz Ibrahim, M.D
Dr. Elmoataz Ibrahim, M.D is a Internal Medicine healthcare provider based in Clinton Township, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1285883371.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Elmoataz Ibrahim, M.D has received a total of $3,429 in payments from pharmaceutical and medical device companies, with $253.09 received in 2024. These payments were reported across 173 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,260).
As a Medicare-enrolled provider, Ibrahim has provided services to 988 Medicare beneficiaries, totaling 1,473 services with total Medicare billing of $128,420. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Access, Student in an Organized Health Care Education/Training Program
- Location Clinton Township, MI
- Active Since 09/12/2008
- Last Updated 11/23/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285883371
Products in Payments
- Briviact (Drug) $350.27
- Aimovig (Biological) $344.25
- AJOVY (Drug) $270.10
- EMGALITY (Drug) $216.21
- AUBAGIO (Drug) $209.06
- APTIOM (Drug) $140.09
- TYSABRI (Biological) $131.09
- AIMOVIG (Biological) $124.22
- REYVOW (Drug) $121.92
- LEMTRADA (Drug) $121.57
- Mavenclad (Biological) $113.67
- NUEDEXTA (Drug) $83.03
- GOCOVRI (Drug) $78.79
- Fycompa (Drug) $71.96
- INBRIJA (Drug) $66.14
- Vimpat (Drug) $64.87
- OCREVUS (Biological) $56.14
- NUPLAZID (Drug) $51.26
- QULIPTA (Drug) $51.10
- Leqembi (Drug) $42.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Clinton Township
Edin Basic, D.o, D.O
Internal Medicine — Payments: $8,777
Linda Lu Kosal, D.o, D.O
Internal Medicine — Payments: $8,569
Bryan Eastes, Md, MD
Internal Medicine — Payments: $7,031
Dr. Harjeet Jhajj, D.o, D.O
Internal Medicine — Payments: $4,551
Dr. Amy Calati, D.o, D.O
Internal Medicine — Payments: $3,876
Dr. James Clinton, D.o, D.O
Internal Medicine — Payments: $3,079